TLSITriSalus Life Sciences, Inc.
- Market cap
- $221.05M
- as of 2026-10-23
- Latest close
- $3.59
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Medical Devices
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2024-01-25
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Szela Mary TCEO and President | Oct 5 | Oct 7 | F | 2,693 | $4.38 | $11,795 | 1,074,990 | No | Form 4 |
| Stevens JenniferChief Regulatory Officer | Oct 5 | Oct 7 | S | 316 | $4.39 | Sale −$1,387 | 123,794 | No | Form 4 |
| Marshak RichardChief Commercial Officer | Oct 5 | Oct 7 | S | 325 | $4.39 | Sale −$1,427 | 127,994 | No | Form 4 |
| Cox Bryan F.Chief of Research | Oct 5 | Oct 7 | S | 296 | $4.39 | Sale −$1,299 | 162,805 | No | Form 4 |
| Patience DavidChief Financial Officer | Jul 1 | Jul 6 | F | 14,650 | $4.46 | $65,339 | 261,107 | No | Form 4 |
| Marshak RichardChief Commercial Officer | Jun 30 | Jul 1 | A | 561 | $3.87 | $2,171 | 128,319 | No | Form 4 |
| Szela Mary TCEO and President | Jun 30 | Jul 1 | A | 3,990 | $3.87 | $15,441 | 1,077,683 | No | Form 4 |
| Marshall Richard HenryChief Medical Officer | Jun 29 | Jun 29 | A | 60,000 | $0.00 | $0 | 90,000 | No | Form 4 |
| Marshall Richard HenryChief Medical Officer | Jun 29 | Jun 29 | A · derivative | 120,000 | $4.74 | $568,800 | 253,000 | No | Form 4 |
| Marshak RichardChief Commercial Officer | May 15 | May 19 | S | 543 | $2.67 | Sale −$1,450 | 125,101 | No | Form 4 |
| Gordon Gary B. | May 15 | May 18 | P | 10,000 | $2.46 | Purchase +$24,600 | 72,510 | No | Form 4 |
| Patience DavidChief Financial Officer | May 15 | May 18 | P | 7,100 | $2.43 | Purchase +$17,253 | 275,757 | No | Form 4 |
| Szela Mary TCEO and President | May 15 | May 18 | P | 39,682 | $2.59 | Purchase +$102,776 | 1,065,215 | No | Form 4 |
| Stansky Michael P | May 15 | May 18 | P | 410,000 | $2.50 | Purchase +$1,025,000 | 1,240,722 | No | Form 4 |
| Stansky Michael P | May 15 | May 18 | P | 200,000 | $2.50 | Purchase +$500,000 | 399,698 | No | Form 4 |
| Wahlstrom Mats | May 15 | May 18 | P | 60,000 | $2.53 | Purchase +$151,800 | 147,555 | No | Form 4 |
| Stansky Michael P | May 14 | May 15 | A | 23,501 | $0.00 | $0 | 810,633 | No | Form 4 |
| Stansky Michael P | May 14 | May 15 | A | 20,089 | $0.00 | $0 | 830,722 | No | Form 4 |
| Stansky Michael P | May 14 | May 15 | A · derivative | 47,003 | $2.52 | $118,448 | 139,540 | No | Form 4 |
| Valle William | May 14 | May 15 | A | 28,201 | $0.00 | $0 | 58,688 | No | Form 4 |
| Valle William | May 14 | May 15 | A | 24,553 | $0.00 | $0 | 83,241 | No | Form 4 |
| Valle William | May 14 | May 15 | A · derivative | 56,403 | $2.52 | $142,136 | 112,653 | No | Form 4 |
| Matlin David J | May 14 | May 15 | A | 28,201 | $0.00 | $0 | 1,300,145 | No | Form 4 |
| Matlin David J | May 14 | May 15 | A | 23,065 | $0.00 | $0 | 1,323,210 | No | Form 4 |
| Matlin David J | May 14 | May 15 | A · derivative | 56,403 | $2.52 | $142,136 | 121,403 | No | Form 4 |
| Gordon Gary B. | May 14 | May 15 | A | 28,201 | $0.00 | $0 | 37,957 | No | Form 4 |
| Gordon Gary B. | May 14 | May 15 | A | 24,553 | $0.00 | $0 | 62,510 | No | Form 4 |
| Gordon Gary B. | May 14 | May 15 | A · derivative | 56,403 | $2.52 | $142,136 | 112,653 | No | Form 4 |
| Wahlstrom Mats | May 14 | May 15 | A | 37,602 | $0.00 | $0 | 53,329 | No | Form 4 |
| Wahlstrom Mats | May 14 | May 15 | A | 34,226 | $0.00 | $0 | 87,555 | No | Form 4 |
| Wahlstrom Mats | May 14 | May 15 | A · derivative | 75,204 | $2.52 | $189,514 | 276,149 | No | Form 4 |
| Hicks Kerry R | May 14 | May 15 | A | 28,201 | $0.00 | $0 | 542,790 | No | Form 4 |
| Hicks Kerry R | May 14 | May 15 | A · derivative | 56,403 | $2.52 | $142,136 | 145,625 | No | Form 4 |
| Frankenius Equity AB | Jul 31, 2025 | Apr 20 | C | 759,000 | $0.00 | $0 | 6,989,748 | No | Form 4 |
| Frankenius Equity AB | Jul 31, 2025 | Apr 20 | C · derivative | 230,000 | $4.00 | $920,000 | not reported | No | Form 4 |
| Matlin David J | Jul 31, 2025 | Apr 1 | C | 330,000 | $0.00 | $0 | 1,271,944 | No | Form 4 |
| Matlin David J | Jul 31, 2025 | Apr 1 | C · derivative | 100,000 | $4.00 | $400,000 | not reported | No | Form 4 |
| Szela Mary TCEO and President | Mar 17 | Mar 20 | S | 15,944 | $3.85 | Sale −$61,384 | 752,987 | No | Form 4 |
| Stevens JenniferChief Regulatory Officer | Mar 16 | Mar 20 | S | 774 | $4.12 | Sale −$3,189 | 124,110 | No | Form 4 |
| Marshak RichardChief Commercial Officer | Mar 16 | Mar 20 | S | 419 | $4.12 | Sale −$1,726 | 110,397 | No | Form 4 |
| Cox Bryan F.Chief of Research | Mar 16 | Mar 20 | S | 579 | $4.12 | Sale −$2,385 | 163,415 | No | Form 4 |
| Devlin JodiChief of Clinical Operations | Mar 16 | Mar 20 | S | 273 | $4.12 | Sale −$1,125 | 97,364 | No | Form 4 |
| Stevens JenniferChief Regulatory Officer | Mar 12 | Mar 20 | S | 1,552 | $4.09 | Sale −$6,348 | 124,884 | No | Form 4 |
| Marshak RichardChief Commercial Officer | Mar 12 | Mar 20 | S | 1,589 | $4.09 | Sale −$6,499 | 110,816 | No | Form 4 |
| Cox Bryan F.Chief of Research | Mar 12 | Mar 20 | S | 1,467 | $4.09 | Sale −$6,000 | 163,994 | No | Form 4 |
| Devlin JodiChief of Clinical Operations | Mar 12 | Mar 20 | S | 1,772 | $4.09 | Sale −$7,247 | 97,637 | No | Form 4 |
| Szela Mary TCEO and President | Mar 11 | Mar 20 | S | 4,358 | $4.13 | Sale −$17,999 | 768,931 | No | Form 4 |
| Stevens JenniferChief Regulatory Officer | Mar 11 | Mar 20 | S | 1,204 | $4.13 | Sale −$4,973 | 126,436 | No | Form 4 |
| Marshak RichardChief Commercial Officer | Mar 11 | Mar 20 | S | 1,449 | $4.13 | Sale −$5,984 | 112,405 | No | Form 4 |
| Cox Bryan F.Chief of Research | Mar 11 | Mar 20 | S | 1,138 | $4.13 | Sale −$4,700 | 165,461 | No | Form 4 |
| Devlin JodiChief of Clinical Operations | Mar 11 | Mar 20 | S | 1,162 | $4.13 | Sale −$4,799 | 99,409 | No | Form 4 |
| Stansky Michael P | Feb 23 | Feb 23 | P | 243,900 | $4.10 | Purchase +$999,990 | 787,132 | No | Form 4 |
| Stansky Michael P | Feb 23 | Feb 23 | P | 117,198 | $4.10 | Purchase +$480,512 | 199,698 | No | Form 4 |
| Szela Mary TCEO and President | Feb 23 | Feb 23 | P | 30,487 | $4.10 | Purchase +$124,997 | 773,289 | No | Form 4 |
| Valle William | Feb 23 | Feb 23 | P | 30,487 | $4.10 | Purchase +$124,997 | 30,487 | No | Form 4 |
| Gordon Gary B. | Feb 23 | Feb 23 | P | 9,756 | $4.10 | Purchase +$40,000 | 9,756 | No | Form 4 |
| Patience DavidChief Financial Officer | Feb 23 | Feb 23 | P | 3,657 | $4.10 | Purchase +$14,994 | 268,657 | No | Form 4 |
| Stansky Michael P | Feb 4 | Feb 11 | A · derivative | 92,537 | $4.91 | $454,357 | 92,537 | No | Form 4 |
| Szela Mary TCEO and President | Nov 24, 2025 | Nov 25, 2025 | A | 125,000 | $0.00 | $0 | 442,802 | No | Form 4 |
| Szela Mary TCEO and President | Nov 24, 2025 | Nov 25, 2025 | A | 300,000 | $0.00 | $0 | 742,802 | No | Form 4 |
| Szela Mary TCEO and President | Nov 24, 2025 | Nov 25, 2025 | A · derivative | 250,000 | $5.55 | $1,387,500 | 1,578,182 | No | Form 4 |
| Patience DavidChief Financial Officer | Nov 24, 2025 | Nov 25, 2025 | A | 65,000 | $0.00 | $0 | 265,000 | No | Form 4 |
| Patience DavidChief Financial Officer | Nov 24, 2025 | Nov 25, 2025 | A · derivative | 130,000 | $5.55 | $721,500 | 668,899 | No | Form 4 |
| Cox Bryan F.Chief of Research | Nov 24, 2025 | Nov 25, 2025 | A | 40,000 | $0.00 | $0 | 166,599 | No | Form 4 |
| Cox Bryan F.Chief of Research | Nov 24, 2025 | Nov 25, 2025 | A · derivative | 80,000 | $5.55 | $444,000 | 261,954 | No | Form 4 |
| Stevens JenniferChief Regulatory Officer | Nov 24, 2025 | Nov 25, 2025 | A | 50,000 | $0.00 | $0 | 127,640 | No | Form 4 |
| Stevens JenniferChief Regulatory Officer | Nov 24, 2025 | Nov 25, 2025 | A · derivative | 100,000 | $5.55 | $555,000 | 323,782 | No | Form 4 |
| Marshak RichardChief Commercial Officer | Nov 24, 2025 | Nov 25, 2025 | A | 60,000 | $0.00 | $0 | 113,854 | No | Form 4 |
| Marshak RichardChief Commercial Officer | Nov 24, 2025 | Nov 25, 2025 | A · derivative | 120,000 | $5.55 | $666,000 | 408,937 | No | Form 4 |
| Devlin JodiChief of Clinical Operations | Nov 24, 2025 | Nov 25, 2025 | A | 50,000 | $0.00 | $0 | 100,571 | No | Form 4 |
| Devlin JodiChief of Clinical Operations | Nov 24, 2025 | Nov 25, 2025 | A · derivative | 100,000 | $5.55 | $555,000 | 463,750 | No | Form 4 |
| Szela Mary TCEO and President | Feb 13, 2024 | Nov 25, 2025 | A | 125,000 | $0.00 | $0 | 317,802 | No | Form 4 |
| Patience DavidChief Financial Officer | Aug 28, 2025 | Aug 29, 2025 | A · derivative | 248,899 | $5.11 | $1,271,874 | 538,899 | No | Form 4 |
| Patience DavidChief Financial Officer | Aug 14, 2025 | Aug 15, 2025 | A | 200,000 | $0.00 | $0 | 200,000 | No | Form 4 |
| Patience DavidChief Financial Officer | Aug 14, 2025 | Aug 15, 2025 | A · derivative | 290,000 | $3.88 | $1,125,200 | 290,000 | No | Form 4 |
| Wahlstrom Mats | Jun 12, 2025 | Jun 27, 2025 | A · derivative | 15,000 | $5.50 | $82,500 | 200,945 | No | Form 4 |
| Valle William | Jun 12, 2025 | Jun 27, 2025 | A · derivative | 15,000 | $5.50 | $82,500 | 56,250 | No | Form 4 |
| Murphy Sean | Jun 12, 2025 | Jun 27, 2025 | A · derivative | 15,000 | $5.50 | $82,500 | 554,681 | No | Form 4 |
| Matlin David J | Jun 12, 2025 | Jun 27, 2025 | A · derivative | 15,000 | $5.50 | $82,500 | 65,000 | No | Form 4 |
| Hicks Kerry R | Jun 12, 2025 | Jun 27, 2025 | A · derivative | 15,000 | $5.50 | $82,500 | 89,222 | No | Form 4 |
| Gordon Gary B. | Jun 12, 2025 | Jun 27, 2025 | A · derivative | 15,000 | $5.50 | $82,500 | 56,250 | No | Form 4 |
| Desai Arjun JJ | Jun 12, 2025 | Jun 27, 2025 | A · derivative | 15,000 | $5.50 | $82,500 | 65,000 | No | Form 4 |
| Stevens JenniferChief Regulatory Officer | May 19, 2025 | May 21, 2025 | A | 28,455 | $5.18 | $147,397 | 86,344 | No | Form 4 |
| Stevens JenniferChief Regulatory Officer | May 19, 2025 | May 21, 2025 | S | 8,704 | $5.18 | Sale −$45,087 | 77,640 | No | Form 4 |
| Murphy Sean | May 19, 2025 | May 21, 2025 | A | 44,884 | $5.18 | $232,499 | 123,989 | No | Form 4 |
| Marshak RichardChief Commercial Officer | May 19, 2025 | May 21, 2025 | A | 21,428 | $5.18 | $110,997 | 75,698 | No | Form 4 |
| Marshak RichardChief Commercial Officer | May 19, 2025 | May 21, 2025 | S | 6,597 | $5.18 | Sale −$34,172 | 69,101 | No | Form 4 |
| Devlin JodiChief of Clinical Operations | May 19, 2025 | May 21, 2025 | A | 24,131 | $5.18 | $124,999 | 57,528 | No | Form 4 |
| Devlin JodiChief of Clinical Operations | May 19, 2025 | May 21, 2025 | S | 4,764 | $5.18 | Sale −$24,678 | 52,764 | No | Form 4 |
| Cox Bryan F.Chief of Research | May 19, 2025 | May 21, 2025 | A | 15,722 | $5.18 | $81,440 | 124,179 | No | Form 4 |
| Cox Bryan F.Chief of Research | May 19, 2025 | May 21, 2025 | S | 4,764 | $5.18 | Sale −$24,678 | 119,415 | No | Form 4 |
| Young James EmmettChief Financial Officer | May 19, 2025 | May 21, 2025 | A | 13,175 | $5.18 | $68,247 | 49,663 | No | Form 4 |
| Devlin JodiChief of Clinical Operations | Feb 18, 2025 | Feb 19, 2025 | A | 5,272 | $0.00 | $0 | 33,397 | No | Form 4 |
| Szela Mary TCEO AND PRESIDENT | Feb 18, 2025 | Feb 19, 2025 | A | 21,089 | $0.00 | $0 | 465,348 | No | Form 4 |
| Marshak RichardChief Commercial Officer | Feb 18, 2025 | Feb 19, 2025 | A | 7,644 | $0.00 | $0 | 54,270 | No | Form 4 |
| Cox Bryan F.CHIEF OF RESEARCH | Feb 18, 2025 | Feb 19, 2025 | A | 11,450 | $0.00 | $0 | 108,457 | No | Form 4 |
| Stevens JenniferCHIEF REGULATORY OFFICER | Feb 18, 2025 | Feb 19, 2025 | A | 14,481 | $0.00 | $0 | 57,889 | No | Form 4 |
| Young James EmmettChief Financial Officer | Feb 18, 2025 | Feb 19, 2025 | A | 14,762 | $0.00 | $0 | 36,488 | No | Form 4 |
| Murphy SeanChief Manuf, Strategy&Bus Dev. | Feb 18, 2025 | Feb 19, 2025 | A | 15,817 | $0.00 | $0 | 79,105 | No | Form 4 |
| Frankenius Equity AB | Feb 10, 2025 | Feb 11, 2025 | J · derivative | 205,853 | $5.28 | $1,086,904 | 435,853 | No | Form 4 |
| Wahlstrom Mats | Feb 10, 2025 | Feb 11, 2025 | J · derivative | 44,750 | $5.28 | $236,280 | 94,750 | No | Form 4 |
| Matlin David J | Feb 10, 2025 | Feb 11, 2025 | J · derivative | 89,501 | $5.28 | $472,565 | 189,501 | No | Form 4 |
| Young James EmmettChief Financial Officer | Feb 5, 2025 | Feb 6, 2025 | P | 6,000 | $5.65 | Purchase +$33,900 | 30,000 | No | Form 4 |
| Szela Mary TCEO AND PRESIDENT | Jan 30, 2025 | Jan 31, 2025 | P | 5,010 | $5.28 | Purchase +$26,453 | 444,259 | No | Form 4 |
| Szela Mary TCEO AND PRESIDENT | Jan 29, 2025 | Jan 31, 2025 | P | 5,030 | $5.03 | Purchase +$25,301 | 439,249 | No | Form 4 |
| Valle William | Jan 29, 2025 | Jan 31, 2025 | A · derivative | 35,000 | $4.89 | $171,150 | 35,000 | No | Form 4 |
| Valle William | Jan 29, 2025 | Jan 31, 2025 | A · derivative | 6,250 | $4.89 | $30,563 | 6,250 | No | Form 4 |
| Gordon Gary B. | Jan 29, 2025 | Jan 31, 2025 | A · derivative | 35,000 | $4.89 | $171,150 | 35,000 | No | Form 4 |
| Gordon Gary B. | Jan 29, 2025 | Jan 31, 2025 | A · derivative | 6,250 | $4.89 | $30,563 | 6,250 | No | Form 4 |
| Murphy SeanChief Manuf, Strategy&Bus Dev. | Jan 28, 2025 | Jan 29, 2025 | P | 15,000 | $5.17 | Purchase +$77,550 | 197,732 | No | Form 4 |
| Szela Mary TCEO AND PRESIDENT | Jan 28, 2025 | Jan 29, 2025 | P | 4,716 | $5.12 | Purchase +$24,146 | 434,219 | No | Form 4 |
| Stevens JenniferCHIEF REGULATORY OFFICER | Jan 27, 2025 | Jan 29, 2025 | A | 10,625 | $0.00 | $0 | 43,408 | No | Form 4 |
| Stevens JenniferCHIEF REGULATORY OFFICER | Jan 27, 2025 | Jan 29, 2025 | A · derivative | 63,750 | $5.30 | $337,875 | 63,750 | No | Form 4 |
| Marshak RichardChief Commercial Officer | Jan 27, 2025 | Jan 29, 2025 | A | 12,500 | $0.00 | $0 | 46,626 | No | Form 4 |
| Marshak RichardChief Commercial Officer | Jan 27, 2025 | Jan 29, 2025 | A · derivative | 75,000 | $5.30 | $397,500 | 75,000 | No | Form 4 |
| Devlin JodiChief of COMMERC. OPERATIONS | Jan 27, 2025 | Jan 29, 2025 | A | 10,625 | $0.00 | $0 | 28,125 | No | Form 4 |
| Devlin JodiChief of COMMERC. OPERATIONS | Jan 27, 2025 | Jan 29, 2025 | A · derivative | 63,750 | $5.30 | $337,875 | 63,750 | No | Form 4 |
| Young James EmmettChief Financial Officer | Jan 27, 2025 | Jan 29, 2025 | A | 12,500 | $0.00 | $0 | 21,726 | No | Form 4 |
| Young James EmmettChief Financial Officer | Jan 27, 2025 | Jan 29, 2025 | P | 24,000 | $5.40 | Purchase +$129,600 | 24,000 | No | Form 4 |
| Young James EmmettChief Financial Officer | Jan 27, 2025 | Jan 29, 2025 | A · derivative | 75,000 | $5.30 | $397,500 | 75,000 | No | Form 4 |
| Cox Bryan F.CHIEF OF RESEARCH | Jan 27, 2025 | Jan 29, 2025 | A | 10,625 | $0.00 | $0 | 97,007 | No | Form 4 |
| Cox Bryan F.CHIEF OF RESEARCH | Jan 27, 2025 | Jan 29, 2025 | A · derivative | 63,750 | $5.30 | $337,875 | 63,750 | No | Form 4 |
| Murphy SeanChief Manuf, Strategy&Bus Dev. | Jan 27, 2025 | Jan 29, 2025 | A | 12,500 | $0.00 | $0 | 63,288 | No | Form 4 |
| Murphy SeanChief Manuf, Strategy&Bus Dev. | Jan 27, 2025 | Jan 29, 2025 | P | 15,000 | $5.31 | Purchase +$79,650 | 182,732 | No | Form 4 |
| Murphy SeanChief Manuf, Strategy&Bus Dev. | Jan 27, 2025 | Jan 29, 2025 | A · derivative | 75,000 | $5.30 | $397,500 | 75,000 | No | Form 4 |
| Szela Mary TCEO AND PRESIDENT | Jan 27, 2025 | Jan 29, 2025 | A | 40,000 | $0.00 | $0 | 424,677 | No | Form 4 |
| Szela Mary TCEO AND PRESIDENT | Jan 27, 2025 | Jan 29, 2025 | P | 4,826 | $5.42 | Purchase +$26,157 | 429,503 | No | Form 4 |
| Szela Mary TCEO AND PRESIDENT | Jan 27, 2025 | Jan 29, 2025 | A · derivative | 240,000 | $5.30 | $1,272,000 | 240,000 | No | Form 4 |
| Hyveled Liselotte | Jan 2, 2025 | Jan 6, 2025 | A | 10,040 | $0.00 | $0 | 10,040 | No | Form 4 |
| Matlin David J | Jan 2, 2025 | Jan 6, 2025 | A | 10,040 | $0.00 | $0 | 941,944 | No | Form 4 |
| Frankenius Equity AB | Dec 17, 2024 | Dec 19, 2024 | P | 62,972 | $3.97 | Purchase +$249,999 | 6,230,748 | No | Form 4 |
| Wahlstrom Mats | Dec 17, 2024 | Dec 19, 2024 | A | 25,188 | $3.97 | $99,996 | 40,915 | No | Form 4 |
| Cox Bryan F.CHIEF SCIENTIFIC & MANUFACT. | Oct 5, 2024 | Dec 19, 2024 | S | 314 | $4.44 | Sale −$1,394 | 86,382 | No | Form 4 |
| Desai Arjun JJ | Dec 10, 2024 | Dec 12, 2024 | S | 30,000 | $3.69 | Sale −$110,700 | 247,127 | No | Form 4 |
| Wahlstrom Mats | Nov 22, 2024 | Nov 25, 2024 | P | 5,000 | $4.55 | Purchase +$22,750 | 15,727 | No | Form 4 |
| Wahlstrom Mats | Nov 21, 2024 | Nov 22, 2024 | P | 8,687 | $4.44 | Purchase +$38,570 | 10,727 | No | Form 4 |
| Wahlstrom Mats | Nov 20, 2024 | Nov 22, 2024 | P | 2,040 | $4.16 | Purchase +$8,486 | 2,040 | No | Form 4 |
| Marshak RichardSR.VP, CORP. DEV. & STRATEGY | Nov 14, 2024 | Nov 15, 2024 | A | 6,875 | $0.00 | $0 | 34,126 | No | Form 4 |
| Marshak RichardSR.VP, CORP. DEV. & STRATEGY | Nov 14, 2024 | Nov 15, 2024 | A · derivative | 41,250 | $4.01 | $165,413 | 41,250 | No | Form 4 |
| Szela Mary TCEO AND PRESIDENT | Sep 13, 2024 | Sep 13, 2024 | P | 1,295 | $4.83 | Purchase +$6,255 | 378,677 | No | Form 4 |
| Szela Mary TCEO AND PRESIDENT | Sep 13, 2024 | Sep 13, 2024 | P | 6,000 | $5.00 | Purchase +$30,000 | 384,677 | No | Form 4 |
| Szela Mary TCEO AND PRESIDENT | Sep 12, 2024 | Sep 13, 2024 | P | 7,520 | $5.20 | Purchase +$39,104 | 377,382 | No | Form 4 |
| Szela Mary TCEO AND PRESIDENT | Sep 10, 2024 | Sep 12, 2024 | P | 5,000 | $4.97 | Purchase +$24,850 | 369,862 | No | Form 4 |
| Martin George Kelly | Aug 28, 2024 | Sep 10, 2024 | S | 9 | $5.50 | Sale −$50 | 247,176 | No | Form 4 |
| Von Eschenbach Andrew C. | Aug 13, 2024 | Aug 21, 2024 | A · derivative | 15,000 | $5.75 | $86,250 | 15,000 | No | Form 4 |
| Singhal Anil K. | Aug 13, 2024 | Aug 21, 2024 | A · derivative | 15,000 | $5.75 | $86,250 | 15,000 | No | Form 4 |
| Desai Arjun JJ | Aug 13, 2024 | Aug 21, 2024 | A · derivative | 15,000 | $5.75 | $86,250 | 15,000 | No | Form 4 |
| Matlin David J | Aug 13, 2024 | Aug 21, 2024 | A · derivative | 15,000 | $5.75 | $86,250 | 15,000 | No | Form 4 |
| Martin George Kelly | Aug 13, 2024 | Aug 21, 2024 | A · derivative | 15,000 | $5.75 | $86,250 | 15,000 | No | Form 4 |
| Hicks Kerry R | Aug 13, 2024 | Aug 21, 2024 | A · derivative | 15,000 | $5.75 | $86,250 | 15,000 | No | Form 4 |
| Hyveled Liselotte | Aug 13, 2024 | Aug 21, 2024 | A · derivative | 15,000 | $5.75 | $86,250 | 15,000 | No | Form 4 |
| Wahlstrom Mats | Aug 13, 2024 | Aug 21, 2024 | A · derivative | 15,000 | $5.75 | $86,250 | 15,000 | No | Form 4 |
| Desai Arjun JJ | Jul 1, 2024 | Jul 2, 2024 | A | 74,000 | not reported | not reported | 277,127 | No | Form 4 |
| Desai Arjun JJ | Jul 1, 2024 | Jul 2, 2024 | D · derivative | 246,667 | not reported | not reported | not reported | No | Form 4 |
| Von Eschenbach Andrew C. | Jun 3, 2024 | Jun 5, 2024 | G · derivative | 35,000 | $11.34 | $396,900 | not reported | No | Form 4 |
| Von Eschenbach Andrew C. | Jun 3, 2024 | Jun 5, 2024 | G · derivative | 35,000 | $11.34 | $396,900 | 35,000 | No | Form 4 |
| Hyveled Liselotte | May 6, 2024 | May 7, 2024 | A · derivative | 35,000 | $9.62 | $336,700 | 35,000 | No | Form 4 |
| Szela Mary TCEO AND PRESIDENT | Feb 13, 2024 | Feb 14, 2024 | A | 84,899 | $0.00 | $0 | 364,862 | No | Form 4 |
| Szela Mary TCEO AND PRESIDENT | Feb 13, 2024 | Feb 14, 2024 | A · derivative | 288,750 | $9.40 | $2,714,250 | 288,750 | No | Form 4 |
| Katz Steven CCHIEF MEDICAL OFFICER | Feb 12, 2024 | Feb 14, 2024 | A | 34,144 | $0.00 | $0 | 68,587 | No | Form 4 |
| Katz Steven CCHIEF MEDICAL OFFICER | Feb 12, 2024 | Feb 14, 2024 | A · derivative | 105,000 | $9.50 | $997,500 | 105,000 | No | Form 4 |
| Murphy SeanCHIEF FINANCIAL OFFICER | Feb 12, 2024 | Feb 14, 2024 | A | 34,144 | $0.00 | $0 | 50,788 | No | Form 4 |
| Murphy SeanCHIEF FINANCIAL OFFICER | Feb 12, 2024 | Feb 14, 2024 | A · derivative | 105,000 | $9.50 | $997,500 | 105,000 | No | Form 4 |
| Devlin JodiPRESIDENT, COMMERC. OPERATIONS | Feb 12, 2024 | Feb 14, 2024 | A | 17,500 | $0.00 | $0 | 17,500 | No | Form 4 |
| Devlin JodiPRESIDENT, COMMERC. OPERATIONS | Feb 12, 2024 | Feb 14, 2024 | A · derivative | 105,000 | $9.50 | $997,500 | 105,000 | No | Form 4 |
| Stevens JenniferCHIEF REGULATORY OFFICER | Feb 12, 2024 | Feb 14, 2024 | A | 14,752 | $0.00 | $0 | 32,783 | No | Form 4 |
| Stevens JenniferCHIEF REGULATORY OFFICER | Feb 12, 2024 | Feb 14, 2024 | A · derivative | 63,750 | $9.50 | $605,625 | 63,750 | No | Form 4 |
| Cox Bryan F.CHIEF SCIENTIFIC & MANUFACT. | Feb 12, 2024 | Feb 14, 2024 | A | 14,752 | $0.00 | $0 | 86,696 | No | Form 4 |
| Cox Bryan F.CHIEF SCIENTIFIC & MANUFACT. | Feb 12, 2024 | Feb 14, 2024 | A · derivative | 63,750 | $9.50 | $605,625 | 63,750 | No | Form 4 |
| Marshak RichardSR.VP, CORP. DEV. & STRATEGY | Feb 12, 2024 | Feb 14, 2024 | A | 14,752 | $0.00 | $0 | 27,251 | No | Form 4 |
| Marshak RichardSR.VP, CORP. DEV. & STRATEGY | Feb 12, 2024 | Feb 14, 2024 | A · derivative | 63,750 | $9.50 | $605,625 | 63,750 | No | Form 4 |
| Marshak RichardSR.VP, CORP. DEV. & STRATEGY | Jan 24, 2024 | Jan 25, 2024 | A · derivative | 40,000 | $9.28 | $371,200 | 40,000 | No | Form 4 |
| Murphy SeanCHIEF FINANCIAL OFFICER | Jan 24, 2024 | Jan 25, 2024 | A · derivative | 125,000 | $9.28 | $1,160,000 | 125,000 | No | Form 4 |